Chun‐Che Liao

Institute of Biomedical Sciences, Academia Sinica — Taiwan

Medicine · Health Sciences

16h-index728citations38works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(19), COVID-19 Clinical Research Studies(13), Viral Infections and Immunology Research(6), Animal Virus Infections Studies(6), Viral gastroenteritis research and epidemiology(5)

Publications38 total

Corrigendum to “Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin” [Biochem. Pharmacol. 215 (2023) 115688]
Biochemical Pharmacology·2025Open Access
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody
JCI Insight·2024· 3 citedOpen Access
Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission
Journal of Biomedical Science·2023· 4 citedOpen Access
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants
Molecular Therapy·2023· 15 citedOpen Access
Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin
Biochemical Pharmacology·2023· 14 cited
Optimization and Improvement of qPCR Detection Sensitivity of SARS-CoV-2 in Saliva
Microbiology Spectrum·2023· 6 citedOpen Access
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan
Journal of Microbiology Immunology and Infection·2023· 6 citedOpen Access
Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511
Pharmaceutics·2023Open Access
Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion
Journal of Medical Virology·2023· 19 citedOpen Access
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern
Emerging Microbes & Infections·2022· 7 citedOpen Access
The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b
Pharmaceutics·2022· 2 citedOpen Access
A booster dose of Delta × Omicron hybrid mRNA vaccine produced broadly neutralizing antibody against Omicron and other SARS-CoV-2 variants
Journal of Biomedical Science·2022· 42 citedOpen Access
Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
Vaccines·2022· 7 citedOpen Access
Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro
EBioMedicine·2021· 61 citedOpen Access
The Effectiveness of Far-Ultraviolet (UVC) Light Prototype Devices with Different Wavelengths on Disinfecting SARS-CoV-2
Applied Sciences·2021· 27 citedOpen Access
NK cell receptor and ligand composition influences the clearance of SARS-CoV-2
Journal of Clinical Investigation·2021· 47 citedOpen Access
Structure-guided antibody cocktail for prevention and treatment of COVID-19
PLoS Pathogens·2021· 27 citedOpen Access
Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide Vaccine
Research Square (Research Square)·2021· 1 citedOpen Access
Vaccinia virus-based vaccines confer protective immunity against SARS-CoV-2 virus in Syrian hamsters
PLoS ONE·2021· 23 citedOpen Access
Small Structural Proteins E and M Render the SARS-CoV-2 Pseudovirus More Infectious and Reveal the Phenotype of Natural Viral Variants
International Journal of Molecular Sciences·2021· 14 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Yi‐Ling Lin(29), Jian‐Jong Liang(23), Chih-Shin Chang(18), Cheng‐Pu Sun(10), Hui‐Ying Ko(10), Mi‐Hua Tao(9), Jia‐Tsrong Jan(8), Sui‐Yuan Chang(7), Yun‐Ju Lai(6), An-Ting Liou(6), Chiaho Shih(6), Ping‐Yi Wu(6), Hsiu‐Hua Ma(6), Cheng‐Wei Yang(6), Yue‐Zhi Lee(6), Ruey‐Bing Yang(6), Tai‐Ling Chao(6), Huey‐Kang Sytwu(6), Shiow‐Ju Lee(6), Hsiang‐Chi Huang(5)